Harvard Drug Study Fraud and Cover-up: How Off-Label Profiteering Works

What's less comprehended is why drug companies spend millions for research o-n uses for their services and products - uses that were never satisfied with the FDA when the drug was submitted for approval. Off-label use allows drug businesses to get 'through the rear door' what they might never, and I mean never, escape with by going right to the FDA for approval for a new use of a solution - what's known today as an off-label use. You'd hope that researchers would not corrupt the testing of the new, or off-label, utilization of a drug to treat kiddies by covering up their consulting charges from Big Pharma. But that's what happened. Harvard Medicine Research Fraud and Cover-up: How Off-Label Profiteering Works Drug organization money corrupts and impacts re-search. For a second viewpoint, we understand people view at: http://www.wbcb.tv/story/30643969/xarelto-lawsuit-says-manufacturers-fraudulently-misrepresented-the-drug . That is confirmed. What is less understood is why drug manufacturers spend billions for re-search on off-label uses for their services and products - if the drug was submitted for approval uses which were never cleared using the FDA. Off-label use allows drug businesses to obtain 'through the rear door' what they could never, and I mean never, escape with by going right to the FDA for approval for a new use of the product - what's known today being an off-label use. You would hope that scientists would not corrupt the experimentation of the new, or off-label, use of a drug to treat young ones by covering up their consulting expenses from Big Pharma. But that is what happened. Visiting http://www.carolinascw.com/story/30643969/xarelto-lawsuit-says-manufacturers-fraudulently-misrepresented-the-drug seemingly provides warnings you might give to your pastor. More crucial than what happened is just why it happened and at the base of this can be a terrible mistake the U.S. has made in allowing the exploitation of off-label use. The devil is in the facts, so here is the story as it has unfolded. Leading Harvard teachers studying off-label uses, the gold-mine of the drug industry, have violated National Institute of Health r-eporting requirements when more than $10,000 has been received from the subject organization, based on the New York Times, 'Researchers Fail to Reveal Drug Pay' June 8, 2008. http://www.nytimes.com/2008/06/08/us/08conflict.html?em&ex=1213070400&en=9971013dfd33290a&ei=508720say20are%20sorry&st=cse is not enough. If Harvard does not fire them, it'll be complicit in the cover-up. Put them off-campus. Ring the bell loud and clear that no matter how renown or exceptional, if you do not play by the rules, you can not play at all. Browse here at the link http://www.keyc.com/story/30643969/xarelto-lawsuit-says-manufacturers-fraudulently-misrepresented-the-drug to learn the purpose of it. If you think you know anything at all, you will possibly require to compare about http://www.carolinascw.com/story/30643969/xarelto-lawsuit-says-manufacturers-fraudulently-misrepresented-the-drug . And the NIH must forever exclude them from receiving grants. Don't throw out the child with the bath water. Provide a chance to these researchers to polish their tarnished reputations, once appropriate punishment is offered. Enable them to conduct research under the supervision of a responsible owner who understands that 'veritas,' means truth, reliability, integrity, and uprightness and that it is significantly more than only a motto. Onward. Richard Alexander http://www.alexanderinjury.com.